Improving outcomes for colitis patients: the HALT-Colitis trial

Status: Ongoing

In this trial we will randomise patients at diagnosis to either just simple first line treatment (5 aminosalicylic acid-5ASA) or 5ASA with Faecal Microbial Transplantation (FMT). This work builds on STOP-Colitis, our previous pilot FMT study in ulcerative colitis.

Project aims

The primary aim of this trial is to see if ‘correction’ of a damaged microbiome can prevent the need for patients to escalate to advance immunomodulatory treatments.